In This Section

Home / Learn / Tumor Boards

Tumor Boards

Tumor boards, also known as multidisciplinary cancer conferences, provide prospective patient case review and assure quality of care evaluation related to diagnosis, treatment, symptom management, follow-up, prehabilitation and/or rehabilitation, and supportive care. Discussion includes, but is not limited to, sharing of expert clinical opinions and treatment recommendations; treatment decision made by attending physician and patient; and opportunities for clinical trial participation.

Disease-site-specific tumor boards focus on certain cancers, for example, breast cancer, lung cancer, prostate cancer, head and neck cancer. 

Molecular tumor board discussion centers around molecular biomarkers and appropriate treatments and clinical trials for patients with tumors that have these markers. 

Featured Program

Virtual Molecular Tumor Boards: An Educational Series

Building on interviews with select ACCC member programs, ACCC and our partner organization, the Association for Molecular Pathology (AMP), developed a webinar series focused on virtual molecular tumor boards for lung and breast cancer. The 12-webinar series features case studies and robust discussions on molecular testing in the community setting.
Learn More

ACCCBuzz Blog Posts

From Oncology Issues

  • Expanding Our Reach
    By Joy Nakhla, RN, BSN, OCN; Viorela Pop, PhD; Lavinia Dobrea, RN, MS, OCN; Lawrence D. Wagman, MD, FACS; and Lars Anker, MD
    St. Joseph Hospital and St. Jude Medical Center combined their neuro-oncology conferences and used video technology to facilitate and improve provider collaboration between institutions. The working model evaluates and addresses current needs while allowing room for additional program growth, having a positive impact on the lives of patients and increasing engagement of physicians within the local community.
  • Development of an Outpatient Cardio-oncology Program
    By Laurie Walton Fitzgerald, MSN, RN, and Peyton Neilson, MSN, RN, OCN
    At University of Maryland Upper Chesapeake Health, the Heart and Vascular Institute and the Kaufman Cancer Center have come together to create a cardio-oncology program that provides a patient-centered, multidisciplinary clinic for cancer patients during diagnosis, treatment, and survivorship.
  • Mind, Body, and Spirit
    By Barbara J. Wilson, MS, RN, AOCN, ACNS-BC; Sara Owens, BSN, RN, OCN; and Chad Schaeffer, MS, FACHE
    Read about the integrative and complementary therapies WellStar Cancer Network provides for its patients. These services act as a “hub for healing” at the new WellStar Cancer Center.
  • Building a Personalized Medicine Program
    Thomas D. Brown, MD, MBA
    The Swedish Cancer Institute (SCI) has a long history of providing the nurturing care of a community-based hospital while giving patients access to the latest cancer therapies. In 2013 we took on the question of how to integrate personalized, genomic medicine into our program.
  •  Closing the Loop with a Post-Biopsy Breast Clinic
    Kimberly C. Hutcherson, MD, and Katherine S. Michaud, MPA
    The Gwinnett Medical Center Breast Program Leadership Team saw an opportunity to create a more comprehensive diagnostic care pathway to include more timely results to breast biopsy patients, streamlined access to treatment specialists, and improved processes and communication with referring physicians.
  • How Molecular Subtyping is Changing Our Understanding of Breast Cancer
    James V. Pellicane, MD, FACS
    This article describes molecular subtyping and shows how it is changing both the understanding of breast cancer and how to treat it. The article summarizes the most important new studies and details the impact of this new information for community cancer centers.
  • How Lean Methodology can Improve Molecular Testing Processes in Advanced NSCLC
    Lawrence D. Wagman, MD, FACS; Raymond Casciari, MD; John Maurice, MD; Peggy J. Crabtree, MBA, RN; and Ruslan Horblyuk, PhD, MBA
    To see how lean methodology could be used to evaluate current molecular testing processes, identify waste, and design an improved process for advanced non-small cell lung cancer (NSCLC) in the community setting, a pilot study was conducted at St. Joseph Hospital, Orange, Center for Cancer Prevention and Treatment (SJH), located in Orange County, Calif.
  • Video-Based Online Global Tumor Boards
    Paul Goss, PhD, FRCP, MB BCh
    Global Cancer Institute (GCI) is the only non-profit completely focused on improving survival rates for under-served cancer patients worldwide.
  • Fox Chase Cancer Center Care Connect
    Kelly Filchner, MSN, RN, OCN, CCRC, and Alan Howald, BS
    Fox Chase Cancer Center, Philadelphia, Pa., committed resources to develop a program to improve communication and education between oncology and primary care, and improve overall survivorship care.
  • Advancing Immuno-Oncology in the Community Setting
    Steven Powell, MD
    As cancer treatment evolves with the emergence of genomics, personalized therapies, and immunotherapies, care delivery must also transform.
  • Building a Palliative Care Program from the Inside Out
    Michelle Abramowski, CRNP, and Patsy Astarita, LCSW-C, OSW-C
    When emerging studies concluded that early palliative intervention with cancer patients leads to better quality of life and reduces cost of care, palliative care became a focus for Kaufman Cancer Center leadership.
  • Strategic Planning for Oncology: Lessons Learned from the Trenches
    Teri U. Guidi, MBA, FAAMA; Jeff Heffelfinger, MSA, D.Min., FACHE; and Gina Myracle, RN
    Despite potential roadblocks, such as organizational restructuring, competitive pressure from external markets, and increased data demands from both public and private payers, it is possible to establish creative and attain-able goals within a strategic plan.